CLINICAL_TRIALS
trial_result
· 2023-10-02
Clinical Trial Update: A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes [Phase 2]
Summary
Phase 2 study evaluating rucaparib in participants with solid tumors and deleterious HRR gene mutations; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: pharmaand GmbH | Conditions: Solid Tumor | Phase 2 | Status: TERMINATED | Results posted: 2023-10-02